https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/2692/expanded-access-protocol-eap/?qd=76002561
EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING IDECABTAGENE VICLEUCEL THAT IS NONCONFORMING...
New life-saving treatments for Multiple Myeloma in clinical trial on EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING IDECABTAGENE VICLEUCEL THAT IS...
expanded access protocolidecabtagene vicleucelthat iseapsubjects
https://www.bmsclinicaltrials.com/us/en/clinical-trials/NCT06045806
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance...
Explore Potential treatments for adults with newly diagnosed Multiple Myeloma who didn't respond well after a stem cell transplant. See if you qualify and...
a studyto compareidecabtagene vicleucelefficacysafety
https://www.avera.org/research-and-clinical-trials/clinical-trials/detail/?id=4
bb2121-EAP-001: Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That...
This study is designed to evaluate the safety and efficacy of nonconforming idecabtagene vicleucel (ide-cel) in subjects with multiple myeloma per the approved...
expanded access protocolidecabtagene vicleuceleapsubjectsreceiving
https://pharmatradz.com/product/idecabtagene-vicleucel-infusion-manufacturers-suppliers/2656
Idecabtagene Vicleucel Infusion — Third Party Manufacturing & Bulk Supply | PharmaTradz
Idecabtagene vicleucel CAR-T infusion for qualified hospitals and transplant centres. Supply only via the authorisation holder's network or named-patient use.
idecabtagene vicleucelthird partybulk supplyinfusionmanufacturing